Taken together, our results from the loss‐of‐function experiments showed that EN1 expression is required for cell survival and metastatic capabilities in vitro and in vivo, suggesting that EN1 and EN1‐related pathways might be potential therapeutic targets for PDA. This evidence concerns the gene EN1 and Patent ductus arteriosus.